Elizabeth B Gray1, Ricardo M La Hoz2, Jaime S Green3, Holenarasipur R Vikram4, Theresa Benedict1, Hilda Rivera1, Susan P Montgomery1. 1. Parasitic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas. 3. Division of Infectious Disease and International Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota. 4. Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona.
Abstract
BACKGROUND: Heart transplantation has been shown to be a safe and effective intervention for progressive cardiomyopathy from chronic Chagas disease. However, in the presence of the immunosuppression required for heart transplantation, the likelihood of Chagas disease reactivation is significant. Reactivation may cause myocarditis resulting in allograft dysfunction and the rapid onset of congestive heart failure. Reactivation rates have been well documented in Latin America; however, there is a paucity of data regarding the risk in non-endemic countries. METHODS: We present our experience with 31 patients with chronic Chagas disease who underwent orthotopic heart transplantation in the United States from 2012 to 2016. Patients were monitored following a standard schedule. RESULTS: Of the 31 patients, 19 (61%) developed evidence of reactivation. Among the 19 patients, a majority (95%) were identified by laboratory monitoring using polymerase chain reaction testing. One patient was identified after the onset of clinical symptoms of reactivation. All subjects with evidence of reactivation were alive at follow-up (median: 60 weeks). CONCLUSIONS: Transplant programs in the United States are encouraged to implement a monitoring program for heart transplant recipients with Chagas disease. Our experience using a preemptive approach of monitoring for Chagas disease reactivation was effective at identifying reactivation before symptoms developed. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Heart transplantation has been shown to be a safe and effective intervention for progressive cardiomyopathy from chronic Chagas disease. However, in the presence of the immunosuppression required for heart transplantation, the likelihood of Chagas disease reactivation is significant. Reactivation may cause myocarditis resulting in allograft dysfunction and the rapid onset of congestive heart failure. Reactivation rates have been well documented in Latin America; however, there is a paucity of data regarding the risk in non-endemic countries. METHODS: We present our experience with 31 patients with chronic Chagas disease who underwent orthotopic heart transplantation in the United States from 2012 to 2016. Patients were monitored following a standard schedule. RESULTS: Of the 31 patients, 19 (61%) developed evidence of reactivation. Among the 19 patients, a majority (95%) were identified by laboratory monitoring using polymerase chain reaction testing. One patient was identified after the onset of clinical symptoms of reactivation. All subjects with evidence of reactivation were alive at follow-up (median: 60 weeks). CONCLUSIONS: Transplant programs in the United States are encouraged to implement a monitoring program for heart transplant recipients with Chagas disease. Our experience using a preemptive approach of monitoring for Chagas disease reactivation was effective at identifying reactivation before symptoms developed. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Luciano Kapelusznik; Deborah Varela; Susan P Montgomery; Arti N Shah; Francis J Steurer; David Rubinstein; Daniel Caplivski; Sean P Pinney; Dana Turker; Stephanie H Factor Journal: Clin Infect Dis Date: 2013-03-28 Impact factor: 9.079
Authors: Fernando Bacal; Christiano Pereira Silva; Edimar Alcides Bocchi; Philippe Vieira Pires; Luiz Felipe P Moreira; Victor Sarli Issa; Silvia Ayub Moreira; Fátima das Dores Cruz; Tânia Strabelli; Noedir Antonio Groppo Stolf; José Antonio Franchini Ramires Journal: Am J Transplant Date: 2005-08 Impact factor: 8.086
Authors: A Riarte; C Luna; R Sabatiello; A Sinagra; R Schiavelli; A De Rissio; E Maiolo; M M Garcìa; N Jacob; M Pattin; M Lauricella; E L Segura; M Vázquez Journal: Clin Infect Dis Date: 1999-09 Impact factor: 9.079
Authors: Mahmoud I Traina; Daniel R Sanchez; Salvador Hernandez; Jason S Bradfield; Mohamed R Labedi; Tarik A Ngab; Frank Steurer; Susan P Montgomery; Sheba K Meymandi Journal: Circ Heart Fail Date: 2015-07-23 Impact factor: 8.790
Authors: José A Pérez-Molina; Ana Pérez-Ayala; Santiago Moreno; M Carmen Fernández-González; Javier Zamora; Rogelio López-Velez Journal: J Antimicrob Chemother Date: 2009-10-09 Impact factor: 5.790
Authors: E P Kransdorf; L S C Czer; D J Luthringer; J K Patel; S P Montgomery; A Velleca; J Mirocha; P C Zakowski; R Zabner; C R Gaultier; Y Qvarnstrom; T Benedict; F Steurer; E Bosserman; C D Paddock; M Rafiei; J A Kobashigawa Journal: Am J Transplant Date: 2013-10-28 Impact factor: 8.086
Authors: Álvaro Martín-Montes; Kristina Kolodová; Clotilde Marín; María José Rosales-Lombardo; Manuel Sánchez-Moreno; Lucía de Andrés-Gordo; Carmen Cano; Lucrecia Campayo; Alberto Gómez-Muñoz; Ana M Sanz; María J R Yunta Journal: ChemMedChem Date: 2021-10-19 Impact factor: 3.540
Authors: Crystal Zheng; Orlando Quintero; Elizabeth K Revere; Michael B Oey; Fabiola Espinoza; Yoram A Puius; Diana Ramirez-Baron; Carlos R Salama; Luis F Hidalgo; Fabiana S Machado; Omar Saeed; Jooyoung Shin; Snehal R Patel; Christina M Coyle; Herbert B Tanowitz Journal: Open Forum Infect Dis Date: 2020-05-06 Impact factor: 3.835
Authors: Mary M Czech; Ashwin K Nayak; Kavitha Subramanian; Jose F Suarez; Jessica Ferguson; Karen Blake Jacobson; Susan P Montgomery; Michael Chang; Gordon H Bae; Shyam S Raghavan; Hannah Wang; Eugenia Miranti; Indre Budvytiene; Stanford Mervyn Shoor; Niaz Banaei; Kerri Rieger; Stan Deresinski; Marisa Holubar; Brian G Blackburn Journal: Open Forum Infect Dis Date: 2021-02-05 Impact factor: 4.423
Authors: Sarah Cristina Gozzi-Silva; Gil Benard; Ricardo Wesley Alberca; Tatiana Mina Yendo; Franciane Mouradian Emidio Teixeira; Luana de Mendonça Oliveira; Danielle Rosa Beserra; Anna Julia Pietrobon; Emily Araujo de Oliveira; Anna Cláudia Calvielli Castelo Branco; Milena Mary de Souza Andrade; Iara Grigoletto Fernandes; Nátalli Zanete Pereira; Yasmim Álefe Leuzzi Ramos; Julia Cataldo Lima; Bruna Provenci; Sandrigo Mangini; Alberto José da Silva Duarte; Maria Notomi Sato Journal: Trop Med Infect Dis Date: 2021-02-10
Authors: Colin J Forsyth; Jennifer Manne-Goehler; Caryn Bern; Jeffrey Whitman; Natasha S Hochberg; Morven Edwards; Rachel Marcus; Norman L Beatty; Yagahira E Castro-Sesquen; Christina Coyle; Paula Stigler Granados; Davidson Hamer; James H Maguire; Robert H Gilman; Sheba Meymandi Journal: J Infect Dis Date: 2022-05-04 Impact factor: 7.759